1. Home
  2. AMTD vs CLNN Comparison

AMTD vs CLNN Comparison

Compare AMTD & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMTD IDEA Group each representing six (6)

AMTD

AMTD IDEA Group each representing six (6)

N/A

Current Price

$0.83

Market Cap

71.2M

Sector

N/A

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

N/A

Current Price

$4.20

Market Cap

57.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMTD
CLNN
Founded
2003
2012
Country
France
United States
Employees
N/A
79
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.2M
57.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
AMTD
CLNN
Price
$0.83
$4.20
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$33.75
AVG Volume (30 Days)
11.2K
72.4K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$200,000.00
Revenue This Year
N/A
$17.64
Revenue Next Year
N/A
$19,516.77
P/E Ratio
$1.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$3.88
52 Week High
$1.65
$13.50

Technical Indicators

Market Signals
Indicator
AMTD
CLNN
Relative Strength Index (RSI) 41.56 40.42
Support Level $0.71 $3.92
Resistance Level $0.80 $4.60
Average True Range (ATR) 0.04 0.34
MACD 0.01 0.06
Stochastic Oscillator 29.95 38.53

Price Performance

Historical Comparison
AMTD
CLNN

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a diversified institution and digital solutions conglomerate group, connecting companies and investors with world-wide markets. The group operates its businesses in five reportable and operating segments: capital market solutions segment, digital solutions and other services segment, media and entertainment segment, hotel operations, hospitality and VIP services segment, and strategic investment segment. The group generates the majority of its revenue from the strategic investment segment that engages in proprietary investments and management of world-wide investment portfolio (including listed and unlisted equity shares investments and movie rights investments). Its geographic areas are China, Europe, America, and Southeast Asia.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: